212-681-1575
Jul

28

Mavis Nye Completes Life-Saving Clinical Trial

Posted by

Label: Treatments


When MesotheliomaHelp first introduced Mavis Nye of England to our readers in 2013, she had been fighting mesothelioma for four years. At that time, she was deep in the throes of the battle of her life and was relentless in

Read Full Story

Want Specific topic updates?


Researcher performs new clinical trial for mesothelioma treatment

In April, MesotheliomaHelp announced the FDA granted Orphan Drug Designation for tremelimumab for the treatment of malignant mesothelioma. The drug was found to increase survival in mesothelioma patients. Now, in a new clinical trial researchers are assessing whether the combination

Read Full Story

Want Specific topic updates?


Early results from an ongoing clinical trial of advanced malignant mesothelioma treatment with a more intensive schedule of tremelimumab has shown clinical and immunological activity and a good safety profile, paving the way for further research into checkpoint inhibitor drugs.

Read Full Story

Want Specific topic updates?


James P. Allison, whose research pioneered the field of cancer immunotherapy, recently described his work to the New York Times in an interview. Cancer immunotherapy isn’t an entirely new field. In 1890 a doctor named William Coley at Memorial Hospital

Read Full Story

Want Specific topic updates?


Medical Research doing some experiments

Once again the European Union has taken the lead in medical care by granting orphan status to a drug touted as bringing a new treatment option to patients with mesothelioma. On June 13, Verastem, Inc. announced its investigational drug VS-6063

Read Full Story

Want Specific topic updates?